Erratum: Bioprocess Development for Mass Production of Size-Controlled Human Pluripotent Stem Cell Aggregates in Stirred Suspension Bioreactor (Tissue Engineering - Part C: Methods (2012) 18: 11 (831-851) DOI: 10.1089/ten.tec.2012.0161);Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor

Tissue Engineering - Part C: Methods

Volumn 18, Issue 11, 2012, Pages 831-851

  Abbasalizadeh, Saeed ^a   Larijani, Mehran Rezaei ^a   Samadian, Azam ^a   Baharvand, Hossein ^a,b  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; BIOCONVERSION; BIOREACTORS; CELL CULTURE; EXPANSION; STEM CELLS;

BIOPROCESS DEVELOPMENT; BIOREACTOR HYDRODYNAMICS; INDUCED PLURIPOTENT STEM CELLS; OXYGEN CONCENTRATIONS; PLURIPOTENT STEM CELLS; STEPWISE OPTIMIZATION; TECHNICAL CHALLENGES; UNDIFFERENTIATED CELLS;

SUSPENSIONS (COMPONENTS);

GLUCOSE; LACTIC ACID DERIVATIVE; OXYGEN;

ANIMAL; ARTICLE; BIOREACTOR; CELL AGGREGATION; CELL CULTURE; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EQUIPMENT; HUMAN; KINETICS; METABOLISM; METHODOLOGY; MOUSE; PLURIPOTENT STEM CELL; SUSPENSION;

ANIMALS; BIOREACTORS; CELL AGGREGATION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GLUCOSE; HUMANS; KINETICS; LACTATES; MICE; OXYGEN; PLURIPOTENT STEM CELLS; SUSPENSIONS;

EID: 84868016949     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2012.0161.correx     Document Type: Erratum

References (37)

1. Rao, M. Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regu-latory issues. Gene Ther 15, 82, 2007.
2. Steiner, D., Khaner, H., Cohen, M., Even-Ram, S., Gil, Y., Itsykson, P., et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol 28, 361, 2010.
3. Fernandes, A.M., Marinho, P.A., Sartore, R.C., Paulsen, B.S., Mariante, R.M., Castilho, L.R., et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz J Med Biol Res 42, 515, 2009.
4. Lock, L.T., and Tzanakakis, E.S. Expansion and differentia-tion of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 15, 2051, 2009.
5. Dame, M.K., and Varani, J. Recombinant collagen for animal product-free dextran microcarriers. In Vitro Cell Dev Biol Anim 44, 407, 2008.
6. McCarthy, K.R., Shannon, S.K., and Verrier, F. Synthetic microcarriers for culturing cells. Google Patents, 2010.
7. Siti-Ismail, N., Bishop, A.E., Polak, J.M., and Mantalaris, A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29, 3946, 2008.
8. Oh, S.K.W., Chen, A.K., Mok, Y., Chen, X., and Lim, U. Long-term microcarrier suspension cultures of human em-bryonic stem cells. Stem Cell Res 2, 219, 2009.
9. Melkoumian, Z., Weber, J.L., Weber, D.M., Fadeev, A.G., Zhou, Y., Dolley-Sonneville, P., et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardio-myocyte differentiation of human embryonic stem cells. Nat Biotechnol 28, 606, 2010.
10. Larijani, M.R., Seifinejad, A., Pournasr, B., Hajihoseini, V., Hassani, S.N., Totonchi, M., et al. Long-term maintenance of undifferentiated human embryonic and induced plu-ripotent stem cells in suspension. Stem Cells Dev 20, 1911, 2011.
11. Amit, M., Laevsky, I., Miropolsky, Y., Shariki, K., Peri, M., and Itskovitz-Eldor, J. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc 6, 572, 2011.
12. Krawetz, R., Taiani, J.T., Liu, S., Meng, G., Li, X., Kallos, M.S., et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tis-sue Eng Part C Methods 16, 573, 2009.
13. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., and Martin, U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc 6, 689, 2011.
14. Serra, M., Brito, C., Costa, E., Sousa, M., and Alves, P. In-tegrating human stem cell expansion and neuronal differ-entiation in bioreactors. BMC Biotechnol 9, 82, 2009.
15. Singh, H., Mok, P., Balakrishnan, T., Rahmat, S.N.B., and Zweigerdt, R Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 4,165, 2010.
16. Olmer, R., Haase, A., Merkert, S., Cui, W., Palecek, J., and Ran, C. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5, 51, 2010.
17. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Mat-sumura, M., Wataya, T., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25, 681, 2007.
18. Xu, Y., Zhu, X., Hahm, H.S., Wei, W., Hao, E., Hayek, A., et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 107, 8129, 2010.
19. Rizzino, A. Stimulating progress in regenerative medicine: improving the cloning and recovery of cryopreserved hu-man pluripotent stem cells with ROCK inhibitors. Reg Med 5, 799, 2010.
20. Baharvand, H., Ashtiani, S.K., Taee, A., Massumi, M., Va-lojerdi, M.R., Yazdi, P.E., et al. Generation of new human embryonic stem cell lines with diploid and triploid karyo-types. Dev Growth Differ 48, 117, 2006.
21. Totonchi, M., Taei, A., Seifinejad, A., Tabebordbar, M., Rassouli, H., Farrokhi, A., et al. Feeder- and serum-free es-tablishment and expansion of human induced pluripotent stem cells. Int J Dev Biol 54, 877, 2010.
22. Mollamohammadi, S., Taei, A., Pakzad, M., Totonchi, M., Seifinejad, A., Masoudi, N., et al. A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum Reprod 24, 2468, 2009.
23. Meuwly, F., Papp, F., Ruffieux, P.A., Bernard, A., Kadouri, A., and Von Stockar, U. Use of glucose consumption rate (GCR) as a tool to monitor and control animal cell produc-tion processes in packed-bed bioreactors. J Biotechnol 122, 122, 2006.
24. Tsao, Y.S., Cardoso, A., Condon, R., Voloch, M., Lio, P., Lagos, J., et al. Monitoring Chinese hamster ovary cell cul-ture by the analysis of glucose and lactate metabolism. J Biotechnol 118, 316, 2005.
25. Zhao, F., Pathi, P., Grayson, W., Xing, Q., Locke, B.R., and Ma, T. Effects of oxygen transport on 3D human mesen-chymal stem cell metabolic activity in perfusion and static cultures: experiments and mathematical model. Biotechnol Prog 21, 1269, 2005.
26. Schop, D., Janssen, F.W., Borgart, E., de Bruijn, J.D., and van Dijkhuizen-Radersma, R. Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism. J Tissue Eng Regen Med 2, 126, 2008.
27. Yirme, G., Amit, M., Laevsky, I., Osenberg, S., and Itskovitz-Eldor, J. Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev 17, 1227, 2008.
28. Andrews, P., Becroft, M., Aspegren, A., Gilmour, J., James, M., McRae, S., et al. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochem J 432, 21, 2010.
29. Chen, G., Gulbranson, D.R., Hou, Z., Bolin, J.M., Ruotti, V., Probasco, M.D., et al. Chemically defined conditions for hu-man iPSC derivation and culture. Nat Methods 8, 424, 2011.
30. Shu, X., Zhu, D., Liu, J., Yin, D., Pang, T., Lu, H., et al. In vitro studies on the growth and proliferation characteristics of rat bone mesenchymal stem cells. Chin J Prev Med 44,923,2010.
31. Chawla, J.S., and Amiji, M.M. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 249, 127, 2002.
32. Kehoe, D.E., Jing, D., Lock, L.T., and Tzanakakis, E.M. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 16, 405, 2010.
33. Niebruegge, S., Bauwens, C.L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., et al. Generation of human em-bryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 102, 493, 2009.
34. Bauwens, C.L., Song, H., Thavandiran, N., Ungrin, M., Massé, S., Nanthakumar, K., et al. Geometric control of car-diomyogenic induction in human pluripotent stem cells. Tissue Eng Part A 17,1901, 2011.
35. Hwang, Y.S., Chung, B.G., Ortmann, D., Hattori, N., Moel-ler, H.C., and Khademhosseini, A. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A 106, 16978, 2009.
36. Kinney, M.A., Sargent, C.Y., and McDevitt, T.C. The multi-parametric effects of hydrodynamic environments on stem cell culture. Tissue Eng Part B Rev 17, 249, 2011.
37. Gassmann, M., Fandrey, J., Bichet, S., Wartenberg, M., Marti, H.H., Bauer, C., et al. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci USA93, 2867, 1996.